CAS 419573-19-6

N-[[(3S,6R)-5-amino-6-[(1R,4R,6R)-4,6-diamino-3-[(2S,4S,5S)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-3-hydroxy-tetrahydropyran-2-yl]methyl]-6-[5-[(4S)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pe

Description:

The chemical substance with the name "N-[[(3S,6R)-5-amino-6-[(1R,4R,6R)-4,6-diamino-3-[(2S,4S,5S)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-3-hydroxy-tetrahydropyran-2-yl]methyl]-6-[5-[(4S)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pe" and CAS number "419573-19-6" is a complex organic molecule characterized by multiple functional groups, including amino, hydroxy, and oxo groups, which suggest potential biological activity. Its structure features several stereocenters, indicating chirality, which can influence its pharmacological properties and interactions with biological systems. The presence of tetrahydropyran and thienoimidazole moieties suggests that it may exhibit properties relevant to medicinal chemistry, potentially acting as a therapeutic agent. The intricate arrangement of its components may contribute to its solubility, stability, and reactivity, making it a subject of interest in drug development and biochemical research. Overall, this compound exemplifies the complexity often found in biologically active molecules, highlighting the importance of stereochemistry and functional group interactions in determining its behavior in biological contexts.

Formula: C₃₄H₆₂N₈O₁₂S

InChI: InChI=1/C34H62N8O12S/c35-15-10-16(36)31(54-33-28(48)25(38)27(47)21(13-43)52-33)29(49)30(15)53-32-17(37)11-19(44)20(51-32)12-40-24(46)7-2-1-5-9-39-23(45)8-4-3-6-22-26-18(14-55-22)41-34(50)42-26/h15-22,25-33,43-44,47-49H,1-14,35-38H2,(H,39,45)(H,40,46)(H2,41,42,50)/t15-,16-,17?,18?,19+,20?,21?,22+,25+,26?,27-,28?,29?,30-,31?,32-,33-/m1/s1

Biotinamidocaproate tobramycin amide

CAS: 419573-19-6

Biotinamidocaproate tobramycin amide is a chemical conjugate, serving as an innovative antimicrobial agent derived from the integration of biotin with tobramycin, an aminoglycoside antibiotic. This product embodies the amalgamation of tobramycin’s robust antibacterial properties with biotin’s ability to guide compounds specifically to targets through biotin-avidin interactions.

Formula: C₃₄H₆₂N₈O₁₂S

Purity: Min. 95%

Molecular weight: 806.97 g/mol

Ref: 3D-AB18613